| Circulating tumor cells (CTCs) |
Cancer monitoring by quantification of CTC |
(7,8) |
| Tumor-derived cell-free DNA |
Screening of gastric and colorectal cancers by detection of methylated cell-free DNA in serum |
(9,10) |
| Screening of EBV-associated cancers |
(11-13) |
| Detection of actionable mutations in tumor-derived cell-free DNA for treatment selection |
(14-22) |
| Tracking progression and clonal evolution of cancers |
(23-26) |
| Tumor-derived cell-free miRNA |
Plasma or serum miRNA for detection of cancers |
(27,28) |
| Extracellular vesicles |
Detection of tumor-derived extracellular vesicles by surface markers in serum of colorectal cancer patients |
(29) |
